{"id":389838,"date":"2020-11-30T14:42:31","date_gmt":"2020-11-30T19:42:31","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=389838"},"modified":"2020-11-30T14:42:31","modified_gmt":"2020-11-30T19:42:31","slug":"fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/","title":{"rendered":"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C."},"content":{"rendered":"
\n

PHILADELPHIA, Nov. 30, 2020 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential securities claims<\/a> on behalf of investors of Fortress Biotech, Inc. (\u201cFortress Biotech\u201d or the \u201cCompany\u201d) (NASDAQ: FBIO<\/a>) to determine whether the Company engaged in securities fraud or other unlawful business practices.<\/p>\n

\n
\n INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, <\/u>
\n <\/strong>
\n
\n THE SECURITIES <\/u>
\n <\/strong>
\n
\n OF <\/u>
\n <\/strong>
\n
\n FORTRESS BIOTECH BETWEEN DECEMBER 11, 2019 AND OCTOBER 9, 2020, BOTH DATES INCLUSIVE (THE \u201cCLASS PERIOD\u201d)<\/u>
\n <\/strong>
\n
\n , <\/u>
\n <\/strong>
\n
\n AND SUFFERED LOSSES<\/u>
\n <\/strong>
\n
\n GREATER THAN $<\/u>
\n <\/strong>
\n
\n 5<\/u>
\n <\/strong>
\n
\n 0,000 <\/u>
\n <\/strong>
\n ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM\u2019S <\/strong>
\n
\n SECURITIES CLASS ACTION QUESTIONNAIRE<\/strong>
\n <\/a>
\n OR CONTACT <\/strong>
\n MICHAEL YARNOFF, ESQ.<\/strong>
\n ,<\/strong>
\n (215) 792-6676, EXT. 804, <\/strong>
\n
\n MYARNOFF@KEHOELAWFIRM.COM<\/strong>
\n <\/a>
\n , <\/strong>
\n
\n SECURITIES@KEHOELAWFIRM.COM<\/strong>
\n <\/a>
\n , TO DISCUSS THE\u00a0<\/strong>
\n
\n SECURITIES INVESTIGATION OR POTENTIAL LEGAL CLAIMS<\/strong>
\n <\/a>
\n . <\/strong>\n <\/p>\n

\n On November 27, 2020, a class action lawsuit was filed against Fortress Biotech<\/strong>
\n in United States District Court, Eastern District of New York. <\/strong>\n <\/p>\n

According to the class action complaint, throughout the Class Period, the Fortress Biotech Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, according to the class action complaint, the Fortress Biotech Defendants made false and\/or misleading statements and\/or failed to disclose that IV Tramadol was not safe for the intended patient population, and that it was foreseeable to them that the FDA would not approve the New Drug Application for IV Tramadol.<\/p>\n

\n Kehoe Law Firm, P.C.<\/a>, with offices in New York and Philadelphia, is a multidisciplinary, plaintiff\u2013side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct.\u00a0 Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.<\/p>\n

This press release may constitute attorney advertising.<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA, Nov. 30, 2020 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Fortress Biotech, Inc. (\u201cFortress Biotech\u201d or the \u201cCompany\u201d) (NASDAQ: FBIO) to determine whether the Company engaged in securities fraud or other unlawful business practices. INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE SECURITIES OF FORTRESS BIOTECH BETWEEN DECEMBER 11, 2019 AND OCTOBER 9, 2020, BOTH DATES INCLUSIVE (THE \u201cCLASS PERIOD\u201d) , AND SUFFERED LOSSES GREATER THAN $ 5 0,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM\u2019S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ. , (215) 792-6676, EXT. 804, MYARNOFF@KEHOELAWFIRM.COM , SECURITIES@KEHOELAWFIRM.COM , TO DISCUSS THE\u00a0 SECURITIES INVESTIGATION OR POTENTIAL LEGAL CLAIMS . On November 27, 2020, a class … <\/p>\n

Continue reading “Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C.”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-389838","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nFortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Nov. 30, 2020 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Fortress Biotech, Inc. (\u201cFortress Biotech\u201d or the \u201cCompany\u201d) (NASDAQ: FBIO) to determine whether the Company engaged in securities fraud or other unlawful business practices. INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE SECURITIES OF FORTRESS BIOTECH BETWEEN DECEMBER 11, 2019 AND OCTOBER 9, 2020, BOTH DATES INCLUSIVE (THE \u201cCLASS PERIOD\u201d) , AND SUFFERED LOSSES GREATER THAN $ 5 0,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM\u2019S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ. , (215) 792-6676, EXT. 804, MYARNOFF@KEHOELAWFIRM.COM , SECURITIES@KEHOELAWFIRM.COM , TO DISCUSS THE\u00a0 SECURITIES INVESTIGATION OR POTENTIAL LEGAL CLAIMS . On November 27, 2020, a class … Continue reading "Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C."\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-30T19:42:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C.\",\"datePublished\":\"2020-11-30T19:42:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/\"},\"wordCount\":293,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/\",\"name\":\"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ=\",\"datePublished\":\"2020-11-30T19:42:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/","og_locale":"en_US","og_type":"article","og_title":"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C. - Market Newsdesk","og_description":"PHILADELPHIA, Nov. 30, 2020 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Fortress Biotech, Inc. (\u201cFortress Biotech\u201d or the \u201cCompany\u201d) (NASDAQ: FBIO) to determine whether the Company engaged in securities fraud or other unlawful business practices. INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE SECURITIES OF FORTRESS BIOTECH BETWEEN DECEMBER 11, 2019 AND OCTOBER 9, 2020, BOTH DATES INCLUSIVE (THE \u201cCLASS PERIOD\u201d) , AND SUFFERED LOSSES GREATER THAN $ 5 0,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM\u2019S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ. , (215) 792-6676, EXT. 804, MYARNOFF@KEHOELAWFIRM.COM , SECURITIES@KEHOELAWFIRM.COM , TO DISCUSS THE\u00a0 SECURITIES INVESTIGATION OR POTENTIAL LEGAL CLAIMS . On November 27, 2020, a class … Continue reading \"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-30T19:42:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C.","datePublished":"2020-11-30T19:42:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/"},"wordCount":293,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/","name":"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ=","datePublished":"2020-11-30T19:42:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NDAzMCMzODQ4ODg3IzIxMjEyMjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/fortress-biotech-investors-who-have-suffered-losses-greater-than-50000-encouraged-to-contact-kehoe-law-firm-p-c\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Fortress Biotech Investors Who Have Suffered Losses Greater Than $50,000 Encouraged to Contact Kehoe Law Firm, P.C."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=389838"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/389838\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=389838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=389838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=389838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}